Evidence map›Paper›PMID 42601480›Full record

ArticleNature2026

Publisher Correction: Targeting cancer-specific mutations with RNA-triggered chromatin shredding.

Jingkun Zeng, Zhiyuan Cheng, Huadong Chen, Zhaojun Wang, Jared Thompson, Kadin T Crosby, Hesong Han, Arushi Singhal, Wayne Ngo, Chenglong Xia and 15 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Nature, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Survival and patterns of recurrence in patients with nasopharyngeal carcinoma from a non-endemic region-A German multicenter analysis.Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al] · 2026
    Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

25 authors.

Jingkun ZengGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Zhiyuan Cheng *Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.ORCID http://orcid.org/0009-0000-3474-2422
Huadong Chen *Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
Zhaojun Wang *Gladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Jared ThompsonDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID http://orcid.org/0009-0006-8557-9702
Kadin T CrosbyDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT, USA.ORCID http://orcid.org/0009-0001-0201-5340
Hesong HanInnovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0000-0001-5545-5238
Arushi SinghalGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Wayne NgoGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.ORCID http://orcid.org/0000-0002-5755-2303
Chenglong XiaInnovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-5895-6342
Daniel Rosas-RiveraGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA.
Zeyuan ZhangInnovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.
Min Hyung KangInnovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.
Ying MaoHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.
Morgan E DiolaitiHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0001-5900-3060
Giselle C LeeThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0002-1794-3094
John F X DiffleyThe Francis Crick Institute, London, UK.ORCID http://orcid.org/0000-0001-5184-7680
Yixuan SongThe Francis Crick Institute, London, UK.
Longhui QiuDepartment of Medicine, University of California, San Francisco, San Francisco, CA, USA.
Nathan M KrahDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID http://orcid.org/0009-0003-8297-7359
Niren MurthyInnovative Genomics Institute, University of California, Berkeley, Berkeley, CA, USA.ORCID http://orcid.org/0000-0002-7815-7337
Ryan N JacksonDepartment of Chemistry and Biochemistry, Utah State University, Logan, UT, USA.ORCID http://orcid.org/0000-0001-7403-3794
Yang LiuDepartment of Biochemistry, University of Utah School of Medicine, Salt Lake City, UT, USA.ORCID http://orcid.org/0000-0002-3889-9707
Alan AshworthHelen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA, USA.ORCID http://orcid.org/0000-0003-1446-7878
Jennifer A DoudnaGladstone Institute of Data Science and Biotechnology, San Francisco, CA, USA. doudna@berkeley.edu.ORCID http://orcid.org/0000-0001-9161-999X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42601480

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.